A new study published in the journal of BMC Advances in Rheumatology found that functional exercise training was more helpful ...

Silo Pharma (SILO) announced a collaboration agreement with Kymanox for specialized design and development of a subcutaneous insertion device ...

Columnist Claire Nielsen shares her personal experience with fibromyalgia and how an anti-inflammatory diet is key.

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

Burgess, J, Marshall, A, Rapteas, L, Riley, D, Matsumoto, K, Boon, C, Alchawaf, A, Ferdousi, M, Malik, RA, Marshall, A, Kaye, ...

Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE ...

Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of its ...

A Ballymoney nail technician who is battling fibromyalgia has spoken of her pride at reaching the finals of a Northern ...

Compared with short-term use, long-term opioid therapy may increase the risk for comorbidities such as depression and sleep disorders among patients with fibromyalgia. Long-term opioid therapy is ...

the Company's ketamine-loaded implant therapeutic targeting fibromyalgia and chronic pain. Under terms of the agreement, ...

Silo Pharma stock is rising after announcing a collaboration with Kymanox to develop a subcutaneous insertion device for its ...